Session L: Enhancing hepatitis C testing and linkage to care
Tracks
.
| Thursday, September 12, 2019 |
| 11:15 AM - 12:15 PM |
| Montreal C & D, Level 11 |
Speaker
Mr Aaron Vanderhoff
Community Outreach And Engagement Lead
Toronto Centre For Liver Disease/Viral Hepatitis Care Network (VIRCAN)
Prof. Jason Grebely
Professor
The Kirby Institute, UNSW Sydney
TIME TO DETECTION OF HEPATITIS C VIRUS INFECTION WITH THE XPERT HCV VIRAL LOAD FINGER-STICK POINT-OF-CARE ASSAY: FACILITATING A MORE RAPID TIME TO DIAGNOSIS
11:30 AM - 11:45 AMBiography
Jason Grebely is a Professor in the Viral Hepatitis Clinical Research Program at the Kirby Institute at UNSW Sydney in Australia.
Dr Emma Robinson
Postgraduate MD Student
University Of Dundee
TARGETED TESTING PATHWAYS IMPROVE HEPATITIS C DIAGNOSIS RATES
11:45 AM - 12:00 PMBiography
Dr. Emma Robinson is a gastroenterology specialist registrar who is currently working towards an MD. Her areas of interest include diagnosis pathways and community care in Hepatitis C.
Dr Jack Stone
Senior Research Associate
University Of Bristol
COST-EFFECTIVENESS OF HEPATITIS C VIRUS SCREENING AND TREATMENT WITH DIRECT-ACTING ANTIVIRALS IN PEOPLE WHO INJECT DRUGS IN NAIROBI, KENYA
12:00 PM - 12:05 PMBiography
Dr Jack Stone is an infectious disease mathematical modeller based in Population Health Sciences at the University of Bristol. His work focuses on hepatitis C virus (HCV) and HIV transmission among high-risk populations, including people who inject drugs, female sex workers and men who have sex with men.
Dr Zoe Ward
Senior Research Associate In Infectious Disease Modelling
University Of Bristol
The cost-effectiveness of an HCV outreach intervention for at-risk populations in London, UK
12:05 PM - 12:10 PMBiography
I am a mathematical biologist interested in infectious disease dynamics and epidemiology. I am currently working on models of hepatitis C virus in populations of people who inject drugs and the impact and cost-effectiveness of harm reduction policies and treatment.
Mr Andrew Radley
Consultant In Public Health Pharmacy
NHS Tayside
USING A SYSTEMS-THINKING APPROACH TO ELUCIDATE PROGRAMME THEORY UNDERPINNING THE EFFECTIVENESS OF SUPERDOT-C: A PHARMACY-LED TEST AND TREAT PATHWAY FOR PWIDS WITH HEPATITIS C INFECTION PRESCRIBED OPIOID SUBSTITUTION THERAPY
12:10 PM - 12:15 PMBiography
Andrew Radley is a Consultant in Public Health at NHS Tayside and a member of the Liver Research Group at University of Dundee. Andrew's research interests are centred around achieving health gain from the pharmacy resource. He is currently completing a PhD programme on Hepatitis C
Chair
Joshua Barocas
Assistant Professor Of Medicine
Boston University School of Medicine
Valérie Martel-laferrière
Physician
CHUM
